Related Experiment Video
Updated: Jul 21, 2026

Detection of Protease Activity by Fluorescent Peptide Zymography
Published on: January 20, 2019
Thrombin-thrombomodulin activation of protein C facilitates the activation of progelatinase A
S R Pekovich1, P E Bock, R L Hoover
1Department of Pathology, C-3321 Medical Center North, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Abstract:
The activation of the matrix metalloproteinase progelatinase A (MMP-2) has been of keen interest because an increase in MMP-2 activity has been implicated in disease states such as cancer and atherosclerosis. Activation of MMP-2 occurs on the surface of specific cell types in two steps. In the first step, primary cleavage of MMP-2 by a membrane-type matrix metalloproteinase generates an intermediate. A secondary cleavage and activation of the intermediate is thought to occur autocatalytically. Previous studies have shown that thrombin can also activate progelatinase A in the presence of endothelial cells. We show that this cell-dependent mechanism of MMP-2 activation also occurs with THP-1 cells and involves binding of thrombin to thrombomodulin present on the cell surface and generation of the anti-coagulant protein, activated protein C. We demonstrate that activated protein C is directly responsible for activation and cleavage of the gelatinase A intermediate. This work contributes new mechanistic insights into the activation of MMP-2 and provides a novel link between matrix metalloproteinase activation and anti-coagulation.
Insights
Matrix metalloproteinase progelatinase A (MMP-2) activation is linked to diseases. Activated protein C, generated via thrombin and thrombomodulin on THP-1 cells, directly cleaves and activates the MMP-2 intermediate.
Area of Science:
- Biochemistry
- Cell Biology
- Molecular Medicine
Background:
- Matrix metalloproteinase progelatinase A (MMP-2) activation is crucial in diseases like cancer and atherosclerosis.
- MMP-2 activation is a two-step process involving primary cleavage and secondary autocatalytic activation.
- Thrombin can activate progelatinase A with endothelial cells.
Purpose of the Study:
- To investigate the mechanism of cell-dependent MMP-2 activation using THP-1 cells.
- To identify the specific molecules involved in thrombin-mediated MMP-2 activation.
- To elucidate the role of activated protein C in MMP-2 activation.
Main Methods:
- Utilized THP-1 cells and thrombin to study MMP-2 activation.
- Investigated the role of thrombomodulin in the cell-dependent activation pathway.
- Assessed the direct involvement of activated protein C in cleaving the MMP-2 intermediate.
Main Results:
- Confirmed cell-dependent MMP-2 activation occurs with THP-1 cells.
- Demonstrated that thrombin binds to cell-surface thrombomodulin, generating activated protein C.
- Showed that activated protein C directly cleaves and activates the MMP-2 intermediate.
Conclusions:
- Activated protein C is the direct activator of the MMP-2 intermediate in this pathway.
- Established a novel link between matrix metalloproteinase activation and anti-coagulation.
- Provided new mechanistic insights into MMP-2 activation on cell surfaces.
More Related Videos
Related Concept Videos
Role of Matrix Metalloproteases in Degradation of ECM
A...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Coagulation
During the coagulation phase, clotting factors, or procoagulants, play a vital role in initiating and progressing the coagulation cascade. This cascade is a series of reactions...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which forms a...
Clot Retraction and Fibrinolysis

